Peter Altman Bio Cardia, Inc. (BCDA) insider trading activity

BCDA Quotes by TradingView

Peter Altman is President and CEO of BioCardia, Inc.. Currently has a direct ownership of 267,966 shares of BCDA, which is worth approximately $329,598. The most recent transaction as insider was on Sep 22, 2022, when has been sold 3,100 shares (Common Stock) at a price of $1.81 per share, resulting in proceeds of $5,611. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 268K
23.62% 3M change
151.42% 12M change
Total Value Held $329,598

Peter Altman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 22 2022
BUY
Open market or private purchase
$5,611 $1.81 p/Share
3,100 Added 0.94%
327,047 Common Stock
Sep 21 2022
BUY
Open market or private purchase
$5,280 $1.92 p/Share
2,750 Added 0.84%
323,947 Common Stock
Jun 10 2022
BUY
Open market or private purchase
$6,570 $1.46 p/Share
4,500 Added 1.38%
321,197 Common Stock
May 13 2022
BUY
Open market or private purchase
$3,723 $1.38 p/Share
2,698 Added 0.77%
348,143 Common Stock
May 12 2022
SELL
Payment of exercise price or tax liability
$41,509 $1.32 p/Share
31,446 Reduced 9.03%
316,697 Common Stock
May 12 2022
BUY
Open market or private purchase
$13,562 $1.2 p/Share
11,302 Added 3.17%
345,445 Common Stock
May 11 2022
BUY
Open market or private purchase
$1,300 $1.3 p/Share
1,000 Added 0.3%
334,143 Common Stock
Apr 29 2022
BUY
Open market or private purchase
$4,347 $1.61 p/Share
2,700 Added 0.8%
333,143 Common Stock
Apr 28 2022
BUY
Open market or private purchase
$3,657 $1.59 p/Share
2,300 Added 0.69%
330,443 Common Stock
Apr 18 2022
BUY
Open market or private purchase
$18,765 $1.39 p/Share
13,500 Added 3.95%
328,143 Common Stock
Apr 14 2022
BUY
Grant, award, or other acquisition
-
76,734 Added 19.61%
314,643 Common Stock
Jan 11 2022
BUY
Open market or private purchase
$187 $1.87 p/Share
100 Added 0.03%
353,715 Common Stock
Nov 18 2021
BUY
Open market or private purchase
$11,000 $2.2 p/Share
5,000 Added 2.06%
237,909 Common Stock
Aug 17 2021
BUY
Open market or private purchase
$10,290 $2.94 p/Share
3,500 Added 1.48%
232,909 Common Stock
Jun 10 2021
SELL
Payment of exercise price or tax liability
$50,338 $4.35 p/Share
11,572 Reduced 4.8%
229,409 Common Stock
Apr 21 2021
SELL
Grant, award, or other acquisition
-
33,581 Reduced 12.23%
240,981 Common Stock
Dec 01 2020
BUY
Open market or private purchase
$2,490 $2.49 p/Share
1,000 Added 0.48%
207,400 Common Stock
Nov 27 2020
SELL
Open market or private sale
$7,392 $2.31 p/Share
3,200 Reduced 1.55%
203,200 Common Stock
Nov 27 2020
BUY
Open market or private purchase
$7,584 $2.37 p/Share
3,200 Added 1.53%
206,400 Common Stock
Nov 13 2020
BUY
Open market or private purchase
$1,045 $2.09 p/Share
500 Added 0.24%
206,400 Common Stock
Nov 12 2020
BUY
Open market or private purchase
$4,120 $2.06 p/Share
2,000 Added 0.96%
205,900 Common Stock
Nov 10 2020
BUY
Open market or private purchase
$4,950 $1.98 p/Share
2,500 Added 1.21%
203,900 Common Stock
PA

Peter Altman

President and CEO
Sunnyvale, CA

Track Institutional and Insider Activities on BCDA

Follow BioCardia, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCDA shares.

Notify only if

Insider Trading

Get notified when an Bio Cardia, Inc. insider buys or sells BCDA shares.

Notify only if

News

Receive news related to BioCardia, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BCDA